Kidney News and Research

RSS

Whitehead Institute researchers identify drug target for anemia

Researchers at Whitehead Institute have identified a protein that is the target of glucocorticoids, the drugs that are used to increase red blood cell production in patients with certain types of anemia, including those resulting from trauma, sepsis, malaria, kidney dialysis, and chemotherapy.

10 Jun 2013

Greenwall Foundation names Peter Reese as 2013 Greenwall Faculty Scholar in Bioethics

The Greenwall Foundation has named Penn Medicine's Peter Reese, MD, MSCE, a leading voice for improving organ donor rates and access to transplant, as a 2013 Greenwall Faculty Scholar in Bioethics.

10 Jun 2013

Doctors create bioengineered blood vessel and implant it in the arm of kidney disease patient

In a first-of-its-kind operation in the United States, a team of doctors at Duke University Hospital helped create a bioengineered blood vessel and implanted it into the arm of a patient with end-stage kidney disease.

7 Jun 2013

Researchers demonstrate how modified citrus pectin works against cancer

A new review by researchers at the University of Maryland School of Medicine highlights a large body of published research demonstrating how modified citrus pectin, works against cancer.

4 Jun 2013

Cancer immunotherapy shows promise in treating patients with metastatic tumors

Cancer immunotherapy is showing promise in treating patients with a variety of advanced, metastatic tumors, as evidenced by two newly unveiled studies from Yale Cancer Center.

4 Jun 2013

Study supports role of skin sodium in blood pressure regulation

It's time to expand the models for blood pressure regulation, according to clinical pharmacologist Jens Titze, M.D. Titze and his colleagues have identified a new cast of cells and molecules that function in the skin to control sodium balance and blood pressure.

4 Jun 2013

Data from Nivolumab phase I study in patients with kidney cancer to be presented at ASCO 2013

Researchers at Dartmouth-Hitchcock Norris Cotton Cancer Center will present a poster on a phase I clinical trial of Nivolumab, a PD-1 receptor blocking antibody, being used in combination with other drugs in patients with metastatic renal cell carcinoma at the ASCO Annual Meeting on June 3, 2013.

4 Jun 2013

New drug shows promising results with manageable side effects for treating melanoma

Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.

3 Jun 2013

Lambrolizumab shows significant antitumor activity in patients with advanced melanoma

Researchers from UCLA's Jonsson Comprehensive Cancer Center led by Dr. Antoni Ribas, professor of medicine in the division of hematology-oncology, report preliminary results showing significant antitumor activity with very manageable side effects from a new drug being tested in patients with advanced melanoma, the deadliest form of skin cancer.

3 Jun 2013

Sorafenib stops tumor growth, provides effective treatment for thyroid cancer patients

The kidney and liver cancer drug sorafenib holds metastatic thyroid cancer at bay for nearly twice as long as a placebo, according to results of a randomized phase III trial, which will be presented today by a researcher from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania in a plenary session during the American Society of Clinical Oncology's annual meeting.

3 Jun 2013

Researchers target possible new weapon in fight against malaria

Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.

1 Jun 2013

New research shows uremic toxins increase heart attack risk

MD-Patients with advanced kidney disease who are undergoing hemodialysis are known to be highly susceptible to heart attacks and other cardiovascular complications, and now scientists likely know why.

31 May 2013

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Exelixis, Inc. today announced it has initiated METEOR, a phase 3 pivotal trial comparing cabozantinib to everolimus in patients with metastatic renal cell carcinoma who have experienced disease progression following treatment with at least one prior VEGFR tyrosine kinase inhibitor.

31 May 2013

Mayo Clinic introduces Individualized Medicine Clinic in Minnesota, Florida and Arizona

You have a serious medical condition, but the conventional tests fail to find an answer. You still have no diagnosis and no effective treatment. What do you do? Mayo Clinic has always been a destination for patients seeking answers. Now, Mayo is taking that concept to the next level with the public launch of its Individualized Medicine Clinic -- at all three of its campuses, in Minnesota, Florida and Arizona.

31 May 2013

Isaiah J. Fidler earns 2013 American Cancer Society Medal of Honor for Basic Research

When Isaiah J. Fidler, D.V.M., Ph.D., left his veterinary surgical practice to pursue a doctorate that would allow him to study and combat the lethal spread of cancer to other organs, he got lots of advice. The common message: Don't go there.

30 May 2013

Ruthenium complexes could pave way for cancer treatments, say UT Arlington researchers

A team of UT Arlington researchers has identified two ruthenium-based complexes they believe could pave the way for treatments that control cancer cell growth more effectively and are less toxic for patients than current chemotherapies.

30 May 2013

Restoring blood vessels may help cure type 1 diabetes, finds University of Missouri scientist

Millions of people with type 1 diabetes depend on daily insulin injections to survive. They would die without the shots because their immune system attacks the very insulin-producing cells it was designed to protect. Now, a University of Missouri scientist has discovered that this attack causes more damage than scientists realized.

30 May 2013

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Adult stem cells combined with new drug could hold key to curing type 1 diabetes

29 May 2013

Spherical nanoparticles transform into netlike structures at site of cancer

Scientists at the University of California, San Diego, have designed tiny spherical particles to float easily through the bloodstream after injection, then assemble into a durable scaffold within diseased tissue. An enzyme produced by a specific type of tumor can trigger the transformation of the spheres into netlike structures that accumulate at the site of a cancer, the team reports in the journal Advanced Materials this week.

29 May 2013

Kidney News and Research

Whitehead Institute researchers identify drug target for anemia

Greenwall Foundation names Peter Reese as 2013 Greenwall Faculty Scholar in Bioethics

Doctors create bioengineered blood vessel and implant it in the arm of kidney disease patient

Researchers demonstrate how modified citrus pectin works against cancer

Cancer immunotherapy shows promise in treating patients with metastatic tumors

Study supports role of skin sodium in blood pressure regulation

Data from Nivolumab phase I study in patients with kidney cancer to be presented at ASCO 2013

New drug shows promising results with manageable side effects for treating melanoma

Lambrolizumab shows significant antitumor activity in patients with advanced melanoma

Sorafenib stops tumor growth, provides effective treatment for thyroid cancer patients

Researchers target possible new weapon in fight against malaria

New research shows uremic toxins increase heart attack risk

Exelixis starts phase 3 pivotal trial of cabozantinib for treatment of metastatic renal cell carcinoma

Mayo Clinic introduces Individualized Medicine Clinic in Minnesota, Florida and Arizona

Isaiah J. Fidler earns 2013 American Cancer Society Medal of Honor for Basic Research

Ruthenium complexes could pave way for cancer treatments, say UT Arlington researchers

Restoring blood vessels may help cure type 1 diabetes, finds University of Missouri scientist

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Adult stem cells combined with new drug could hold key to curing type 1 diabetes

Spherical nanoparticles transform into netlike structures at site of cancer

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News